ENDOCYTE INC's ticker is ECYT and the CUSIP is 29269A102. A total of 73 filers reported holding ENDOCYTE INC in Q4 2017. The put-call ratio across all filers is 1.41 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $244,000 | -2.0% | 57,200 | -67.6% | 0.01% | 0.0% |
| Q3 2017 | $249,000 | +40.7% | 176,700 | +49.4% | 0.01% | +18.2% |
| Q2 2017 | $177,000 | -23.0% | 118,300 | +58.6% | 0.01% | -42.1% |
| Q3 2016 | $230,000 | -38.7% | 74,610 | -36.2% | 0.02% | -45.7% |
| Q2 2016 | $375,000 | +4.2% | 116,900 | +0.5% | 0.04% | -2.8% |
| Q1 2016 | $360,000 | -22.7% | 116,300 | 0.0% | 0.04% | -39.0% |
| Q4 2015 | $466,000 | +109.0% | 116,300 | +226.7% | 0.06% | +59.5% |
| Q4 2014 | $223,000 | -80.6% | 35,600 | -58.7% | 0.04% | -85.9% |
| Q3 2013 | $1,149,000 | -25.1% | 86,200 | -26.7% | 0.26% | -36.0% |
| Q2 2013 | $1,535,000 | – | 117,600 | – | 0.41% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management II, LLC | 4,300,000 | $59,340,000 | 17.76% |
| RA Capital Management | 5,649,884 | $77,968,000 | 5.06% |
| Avoro Capital Advisors LLC | 5,695,200 | $78,594,000 | 3.03% |
| Crosspoint Capital Strategies, LLC | 107,620 | $1,485,000 | 2.84% |
| Ghost Tree Capital, LLC | 500,000 | $6,900,000 | 2.03% |
| EMORY UNIVERSITY | 205,295 | $2,833,000 | 1.88% |
| Asymmetry Capital Management, L.P. | 103,159 | $1,424,000 | 1.40% |
| NEXTHERA CAPITAL LP | 596,000 | $8,225,000 | 1.27% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,324,299 | $32,075,000 | 1.13% |
| PFM Health Sciences, LP | 4,068,608 | $56,147,000 | 0.88% |